Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB311495

CLEC9a Antibody (7H11), PE/Atto594, Novus Biologicals™
SDP

Catalog No. NB311495 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB311495 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB311495 Supplier Novus Biologicals Supplier No. FAB67761PEATT594
Add to Cart
Add to Cart

Description

Rat Monoclonal Antibody

CLEC9a Monoclonal antibody specifically detects CLEC9a in Mouse samples. It is validated for Flow Cytometry

Specifications

Antigen CLEC9a
Applications Flow Cytometry
Classification Monoclonal
Clone 7H11
Conjugate PE/ATTO 594
Dilution Flow Cytometry
Formulation PBS
Gene Alias C-type lectin domain family 9 member A, C-type lectin domain family 9, member A, DNGR1, HEEE9341, UNQ9341
Host Species Rat
Immunogen RBL-2H3 rat basophilic leukemia cell line expressing mouse CLEC9a fused to an HA epitope, Accession # Q8BRU4
Purification Method Protein A or G purified from hybridoma culture supernatant
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Immunology, Stem Cells
Primary or Secondary Primary
Gene ID (Entrez) 283420
Target Species Mouse
Content And Storage Store at 4C in the dark. Do not freeze.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.